1. Introduction {#s0005}
===============

Betulaceae (birch family) is an important group of the Angiosperms comprising of 6 plant genera *viz. Alnus* (Alders), *Betula* (Birches), *Carpinus* (Hornbeams), *Corylus* (Iron-wood), *Ostrya* (Hazel) and *Ostryopsis* (Hazel-hornbeam). It is most common in the northern hemisphere, but can occasionally be found in the southern hemisphere especially South America. *Betula* is the largest genus of this family and includes 119 accepted names, till date, based on The Plant List ([@bib66]).

Trees and shrubs of this genus inhabit various ecosystems in temperate and boreal climate zones of the northern hemisphere. Distribution of different *Betula* species around the world is depicted in [Fig. 1](#f0005){ref-type="fig"}. Birches are among the most attractive trees known for their autumn color and contribute to the fall color in eastern North America. Various birches have yielded sugar, vinegar, a tea from the leaves, and a birch beer from the sap. The sweet, birch (*Betula lenta* L.) is now the chief source of oil of wintergreen ([@bib6], [@bib64]). *Betula utilis* D. Don, found in the Himalayan region of India, is used in religious ceremonies in north region ([@bib130]).Fig. 1Distribution areas of *Betula* species.

The healing properties of *Betula* bark and bark extracts have been known for a long time in traditional medicine in different parts of the world. Different *Betula* species find mention in several pharmacopoeias ([@bib108], [@bib147]) including the Russian, French, European, Deutsches Pharmacopoeias, the Ayuevedic Pharmacopoeia of India and Pharmacopoeia Jugoslavica. Several classical texts as well as modern books also contain monographs that describe the botanical, chemical, as well as pharmacological properties and uses of *Betula* species ([@bib161], [@bib41], [@bib104], [@bib56], [@bib32], [@bib30], [@bib31], [@bib169]).

The *Betula* species exhibit various pharmacological properties. Their chemistry is complex and they are known to contain molecules of therapeutic importance. In the last few decades, several studies have been carried out that also provide evidence in favor of their conventional uses. The purpose of this review is to provide comprehensive information on the botany, traditional uses, phytochemistry, pharmacological and toxicological research of *Betula* species in order to explore their therapeutic potential, highlight the lacunae in our present knowledge and evaluate future research opportunities. All the available information on various species belonging to the genus *Betula* was collected *via* electronic search (using Pubmed, SciFinder, Scirus, Google Scholar, JCCC\@INSTIRC and Web of Science) and a library search for articles published in peer-reviewed journals. This review thus provides the scientific basis for future research on species belonging to this genus.

2. Distribution and botanical description {#s0010}
=========================================

*Betula* is a genus of tree and shrubs, monecious, leaves simple alternate, deciduous penninerved, toothed or serrate. Male flower in pendulous spikes; bracts peltate; with 3 bi-bracteolate flowers; sepals 2--4; stamens 2, filaments forked separating the anther cells. Female flower in erect or pendulum spikes; bracts imbricate, bracteoles 2 adnate to the bract which thus appears 3-lobbed; perianth 0; ovary compressed, 2-celled, cells 1-ovuled; styles 2, slender, stigmas terminal. Fruit a spike of lenticular winged or margined nuts; cotyledons flat. The genus *Betula* is widely distributed from North temperate and arctic regions, circle to, the Himalayas, Afghanistan, China, Japan, Kazakhstan, Korea, Kyrgyzstan, Mongolia, Nepal, Russia, Sikkim, southern Europe, and extending to the North and South America ([@bib61], [@bib5], [@bib44]).

*Betula pendula* Roth (silver birch) and *Betula pubescens* Ehrh. (downy birch) both have wide distribution in Europe and are also found in northern parts of Asia ([@bib54]; [@bib500]). *Betula alnoides* is found widely distributed in E. Asia---Himalayas to S.W. China. *Betula alleghaniensis* Britton (yellow birch), *Betula lenta* L. (sweet birch), *Betula papyrifera* Marshall (paper birch) *Betula populifolia* Marsh. (gray birch) and *Betula nigra* L. (river birch) are species typical for North America ([@bib54]). In Scandinavia and northern Europe *Betula pendula* is an important tree species for forest industry, but also used as amenity trees in parks, alleys and in gardens. *Betula alleghaniensis*, *Betula lenta* and *Betula papyrifera* are also valuable for forest industry. Birches are cold tolerant pioneer species and in southern Europe they are found mainly on higher altitudes. Many *Betula* species such as *Betula nana* L. (dwarf birch), *Betula pubescens* subsp. *czerepanovii* (Orlova) Hämet-Ahti (arctic moor birch) and *Betula utilis* D. Don (Himalayan birch) are typical for treeline. *Betula nana* and its subspecies are shrubs native to arctic and cool temperate regions of northern Europe, northern Asia and northern North America. They are also present in Greenland as well as in mountains in Scotland and the Alps. *Betula utilis* is growing as a shrub or tree native to the Himalayas ([@bib54], [@bib65]).

However, the taxonomy of the European members of the genus has long been in dispute because of their high morphological variability and frequent hybridization ([@bib7]). Difficulties in distinguishing between closely related birch species have prompted numerous biometric and chemotaxonomic studies. The former have been based mainly on morphological characteristics of birch leaves and fruits (reviewed in [@bib7]), and the latter on the composition of phenolics (particularly flavonoids) and terpenoids in birch leaves, buds, bark and stems (reviewed in [@bib79]). Besides these, studies have also been conducted to determine the phylogenetic relationships in *Betula* based on amplified fragment length polymorphisms (AFLP) markers ([@bib141]), nuclear alcohol dehydrogenase genes (ADH) and chloroplast MaturaseK (*MatK*) gene sequences ([@bib71]). [@bib70] studied the important ecological characteristics and typical growth and yield patterns of two commercially important treelike birch species (*Betula pendula* and *Betula pubescens*) that occur naturally in Europe.

3. Traditional uses and ethnopharmacology {#s0015}
=========================================

The available literature and information show that several *Betula* species have traditionally been used as medicine in different parts of the world. The most widespread use has been in the treatment of bone related problems including arthritis, rheumatism and gout as well as renal ailments. Birch sap has also been recommended against hepatitis, rash, intestinal worms and scurvy. Besides the medicinal uses, cosmetic applications have also been reported, mainly for hair growth and against freckles. Tea infusion of *Betula pendula* has also been frequently used in Europe, specially the Czech Republic, in herbal teas ([@bib21]).

[Table 1](#t0005){ref-type="table"} presents the various ethnobotanical uses of those *Betula* species that have been widely used in the different parts of the world and documented. The local names as well as the methods of administration and the induced effects that have been reported have also been mentioned.Table 1Ethnomedicinal uses of *Betula* species.**Plant nameVernacular name (Locality)Part usedEthnobotanical usesRef.***Betula alnoides* Buch.-Ham. ex D. DonPaiyun (Jajarkot district, Nepal)BarkA decoction of the bark is boiled to a gelatinous mass which is applied to treat micro-fracture or dislocated bone.[@bib101], [@bib102]BarkBark is boiled with water and the liquid mass is applied to dislocated bone and injury. Bark is chewed orally to treat sore throat and to check excessive menstruation.[@bib128]*Betula papyrifera* Marsh.Paper birch (USA)Whole plantUsed as a preservative[@bib111]*Betula pendula* RothBreza (Bosnia and Herzegovina)Leaf, BarkFluid unction with *Arctium lappa* for increased growth of hair and dandruff (*Arnica, Betula*)[@bib12]Juice for renal gravel.Tea for renal ailments, rheumatism and blood purificationTea for urinary tract infections (*Betula, Althaea officinalis, Equisetum, Salvia, Uva*), (*Betula, Althaea officinalis, Equisetum, Salvia*)Tea for renal ailments (*Betula, Salix*), (*Betula, Ocimum, Solidago*)Decoct for asthma (*Betula, Pimpinella major, Pimpinella saxifraga, Potentilla, Ruta*)Decoct for hindered diuresis (*Betula, Saponaria, Solidago*)Decoct for rheumatism (*Betula, Populus alba, Sambucus nigra, Tilia, Urtica*), (*Betula, Sambucus nigra, Tilia, Urtica*)Decoct for enlarged spleen (*Betula, Coriandrum*)Breza Silver birch (Bosnia and Herzegovina; Western Balkan Peninsula; Southeast Europe)Bark, LeavesUsed for renal diseases and ague[@bib13]As a mixture with other drugs, used for urogenital tract ailments: urinary bladder infections, urinary tract infections, purification of urinary bladder, renal inflammations, renal stones and hindered diuresis; for arrhythmia, blood purification, purification of lungs, rheumatism, arthritis, common cold and feverUrogenital tract ailments, rheumatism, skin problems, blood system disorders, respiratory tract ailments and influenzal infections.Breza (Prokletije Mountains; Montenegro)LeavesBacterial and inflammatory disease of the urinary tract and for kidney stones[@bib108]Externally for hair loss and dandruffBreza (Bulgaria)BarkInfusion, decoction; diuretic, cholagogue[@bib91]Oqkayın (Toshkent, Djizzax, and Samarqand provinces; Uzbekistan, Central Asia)ResinAgainst rheumatic pain; ingested 3 times a day for 3 weeks[@bib144]Batoula (Lebanon)LeavesArthritis-sleep in a sack filled with leaves[@bib103]Arthritis and rheumatism-decoction for bathingBedoll (Pallars; Pyrenees, Catalonia, Iberian Peninsula)Bark, LeavesOral; Tisane (infusion or decoction), direct ingestion is antiarthrosic, useful against hypercholesterolemia, anticephalalgic, anticholagogue, antihelminthic, salutiferous[@bib1]Bidollo betulla Silver birch (Marches region; Central-Eastern Italy)BarkDecoction, in external washes; to prevent hair loss[@bib125]Buds and leavesDecoction, in external application; cicatrizingBetulla (Italy)BarkInfusion, decoction; antipyretic, diuretic, cholagogue, diaphoretic[@bib91]Infusion, decoction; in skin diseasesBetulla (Lucca Province, north-west Tuscany, central Italy)Bark and sapAgainst cold[@bib123]Against alopecia (decoction of the bark, then adding sap)Symida (Thessaloniki (N Greece)LeavesInfusion, decoction; for metabolic diseases (urea, uric acid), systematic diseases (arthritis, rheumatisms), skin diseases (cellulites) and urogenital system (diuretic, renal disorders)[@bib55]Silver Birch (Transylvania, East and Central Romania)LeavesAs a foment for cold;[@bib121]As a bath and foment for rheumatism and arthritis;For kidney stones as a tea with *Alnus glutinosa, Origanum vulgare* and *Equisetum arvense*;For heart and liver disease, flatulence and renal pain, for gall stonesBarkFor wounds.SapFor kidney disease; as an appetite stimulant, for stomach and liver disease; for colds; for chilblain as a foment.*Betula platyphylla* Sukat. var. *japonica* (Miq.) HaraJajaknamu (Southern mountainous region of Korea)StemDecoction given orally; bone diseases[@bib83]*Betula pubescens* Ehrh. Syn-*Betula alba* LBatoula (Morocco: Tafilalet)Aerial partCardiac disease; hypertension[@bib28]Abedul, bidueiro (El Caurel; Galicia, northwest Spain)Sap fresh plantBath, as a vulnerary[@bib11]InflorescencesDecoction is used against goutVidoeiro Vido (Tras-os-Montes; northern of Portugal)Flowers, leaves, bark and resin (in Spring).Bile stimulant; diuretic; soporific and anti-edema; against cholesterol and urea; against gout; calculus[@bib117]Anti-edema; anti-podagric; cholagogue; complexion; diaphoretic; diuretic; hypocholesterolemia; lithiasis treatment; vulnerary(West Azerbaijan; Iran)Leaves*Sambucus nigra* L. flowers in combination with *Arctium lappa* L. leaves, *Malva sylvestris* L. leaves, *Betula alba* L. leaves; all the ingredients are boiled in 1 l of water and then clean clay is added in order to produce a cream to be applied to epidermis[@bib110]*Betula pumila* L. var. *glandulifera* RegelBog birch (USA)FlowerSmoke inhalation used for respiratory tract diseases[@bib111]*Betula utilis* D.DonJoonsh, Zhoonsh (Bulashbar Nullah, Astore; Northern Pakistan)BarkLocal people cover Desi ghee in its bark and burry in the soil; as the time passes (10--20 years), the taste of Ghee becomes pleasant. This ghee is more valuable than normal Desi Ghee[@bib149]Due to the water proof nature of the paper, they spread this paper on the roofs of their houses like sheets during construction as well as cover the potatoes and wheat which are present in small digs made in the fieldsTowa (Western Ladakh, India)Bark, RootJaundice, burns, leprosy and bronchitis[@bib4]Bhuj (Humla district; Western Nepal)BarkWounds are covered by papery barks for antiseptic purpose[@bib133]For the storage of food grains, the hole is dug in the ground and all sides of hole are covered by papery barks supported by young branches of *Pinus wallichiana*. The hole is filled with food grains, covered by soil and stored for futher useBirch (Leepa valley; Azad Jammu and Kashmir, Pakistan)BarkPowder taken orally; used for leprosy and convulsion; tonic[@bib96]Bhojpattra (India)Stem barkAbortifacient[@bib98]Bhojpattra (Johari tribals; Uttarakhand, India)Stem barkAntiseptic, for ear complaint, hysteria, jaundice[@bib99] and [@bib19]Bhojpattra (Garhwal Himalayan region of Uttarakhand, India)Stem barkFor wounds[@bib116]Bhojpattra (North India)ResinFor cuts and burns[@bib145] and [@bib146]ContraceptiveBhuj (Nepal)BarkA paste made from the bark is used as a poultice on cuts, wounds and burns.[@bib102]BarkDecoction is used for sores.[@bib128]Bhuj (Dolpa, Nepal)BarkPoultice used in wounds, swellings *etc.*[@bib48]ResinUsed in bile and phlegm disorders.Buspath (Manang, Nepal)Bark and leavesMixture of bark and leaves with other herbs is used to treat fever.[@bib48] and [@bib47]Bark and resinAntiseptic, carminative. Bark decoction is useful for sore throat. Bark is used for bacterial infections, skin diseases, bronchitis cough.[@bib10]*Betula* species (*Betula pendula*, and *Betula pubescens*)Birch (Northern, Central and Eastern Europe)Tree sapLung diseases, gout, skin diseases, infertility, revitalization, stomach diseases, kidney stones, jaundice, diuretic, rheumatism, arthritis, liver disease, pneumonia, cholera.[@bib156]

4. Chemical constituents {#s0020}
========================

Detailed and extensive phytochemical investigations are necessary for understanding the pharmacological activity of the species, to gain an understanding of the mechanisms of action and for quality control purposes. Chemical investigations of the different species of this genus have led to the isolation and identification of several groups of chemical constituents. Basic phytochemical groups as well as the structures of the correspomding compounds that have been isolated and reported from *Betula* species are shown in [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"}, [Fig. 6](#f0030){ref-type="fig"}, [Fig. 7](#f0035){ref-type="fig"}, [Fig. 8](#f0040){ref-type="fig"} whereas their related information is shown in [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}, [Table 5](#t0025){ref-type="table"}, [Table 6](#t0030){ref-type="table"}, [Table 7](#t0035){ref-type="table"}, [Table 8](#t0040){ref-type="table"}.Fig. 2Structures of triterpenoids of *Betula* species.Fig. 3Structures of diarylheptanoids of *Betula* species.Fig. 4Structures of phenylbutanoids of *Betula* species.Fig. 5Structures of phenolics of *Betula* species.Fig. 6Structures of flavonoids, flavones and flavanones of *Betula* species.Fig. 7Structures of catechins and lignans of *Betula* species.Fig. 8Structures of steroids and miscellaneous compounds 123--137.Table 2Triterpenoids isolated from *Betula* species.NameSpecie from which isolatedReference**Ocotillol series1**12-O-acetylbetulafolienetetraol oxide*Betula dahurica*[@bib37]**2**20(*S*),24(*R*)-epoxydammaran-3β*Betula ermanii*[@bib38]**3**11α,25-triol, 3-O-β-[d]{.smallcaps}-glucopyranoside of 2*Betula ermanii*[@bib38]**4**2′-acetate of 3*Betula ermanii*[@bib38]**5**11,2′-diacetate of 3*Betula ermanii*[@bib38]**6**12β-acetoxy-20(*S*),24(*R*)-epoxy-3α,17 α,25-trihydroxydammarane*Betula maximowicziana*[@bib39]**7**20(*S*),24(*R*)-epoxy-3α,17 α,25-trihydroxydammarane*Betula maximowicziana*[@bib39] and [@bib170]**8**3-epi-ocotillol II*Betula maximowicziana*[@bib39]**9**12β-acetoxy-20(*S*),24(*R*)-epoxy-3α, 25-dihydroxydammarane*Betula maximowicziana*[@bib39]**10**12β-acetoxy-20(*S*),24(*R*)-epoxy-3α,17 α,25-trihydroxydammarane 3-O-β-[d]{.smallcaps}-glucopyranoside (=betulamaximoside A)*Betula maximowicziana*[@bib39]**11**12β-acetoxy-20(*S*),24(*R*)-epoxy-3α,17 α,25-trihydroxydammarane 3-O-β-[d]{.smallcaps}-(6-O-acetyl)-glucopyranoside (=betulamaximoside B)*Betula maximowicziana*[@bib39]**12**12-O-acetyl-20,24-epoxy-3α,12β,20(S),24(*R*),25-pentahydroxydammar-3-yl hydrogen propanedioate (=papyriferic acid)*Betula neoalaskana*[@bib107], [@bib157], [@bib35], and [@bib59]*Betula pendulaBetula pendulaBetula platyphylla***13**Deacetylpapyriferic acid*Betula pendula*[@bib157]**14**Ocotillol II 3-O-caffeate*Betula platyphylla*[@bib35]**15**3-O-methylmalonyl-3α,17α,25-trihydroxy-20(*S*),24(*R*)-epoxydammarane*Betula platyphylla*[@bib170]**16**12β-acetoxyl-ocotillone*Betula platyphylla*[@bib170]**17**Ocotillol*Betula platyphylla*[@bib170]**18**3-O-ethylmalonylepiocotillol II*Betula platyphylla*[@bib170]**19**3-O-butylmalonylepiocotillol II*Betula platyphylla*[@bib170]**20**Ethyl papyriferate*Betula platyphylla*[@bib170]**21**Butyl papyriferate*Betula platyphylla*[@bib170]**Dammarane seriesType I22**Dammar-24-en-3β,11α,20(*S*)-triol*Betula ermanii*[@bib38]**23**3-O-β-[d]{.smallcaps}-2-O-acetylglucopyranoside of 22*Betula ermanii*[@bib38]**24**Dammarendiol II 3-caffeate*Betula ermanii*[@bib38]**25**12-O-acetylbetulafolienetetraol*Betula maximowicziana*[@bib39]**26**Betulafolienetetraol*Betula maximowicziana*[@bib39]**27**Dammarenediol II 3-O-caffeate*Betula maximowicziana*[@bib39]**28**12-O-acetylbetulafolienetriol*Betula platyphylla*[@bib35]**29**12-O-acetyl-3-O-malonylbetulafolienetriol*Betula platyphylla*[@bib35]**30**12-O-acetylbetulafolienediolone*Betula platyphylla*[@bib35]**31**Dammarenediol II 3-O-*p*-coumarate*Betula platyphylla*[@bib35]**32**Dammarenediol II 3-O-caffeate*Betula platyphylla*[@bib35]**33**12-O-acetyl-3α,12β,17α,20(*S*)-tetrahydroxydammar-24-en-3-yl hydrogen propanedioate*Betula pendula*[@bib59]**Type II34**Dammar-24-ene-3β, 20(*S*),26-triol 3-O-caffeate*Betula maximowicziana*[@bib39]**35**Dammar-24-ene-3β, 20(S),26-triol 3-O-*p*-coumarate*Betula maximowicziana*[@bib39]**Type III36**20(*S*)-hydroxy-25-methoxy-dammar-23-en-3-one*Betula platyphylla*[@bib170]**37**3α,20(*S*)-dihydroxy-25-methoxy-dammar-23-ene*Betula platyphylla*[@bib170]**38**12-O-acetyl-3α,12β,20(*S*),25-tetrahydroxydammar-23(*E*)-en-3-yl hydrogen propanedioate*Betula pendula*[@bib59]**39**12-O-acetyl-3α,12β,17α,20(*S*),25-pentahydroxydammar-23(*E*)-en-3-yl hydrogen propanedioate*Betula pendula*[@bib59]**Type IV40**12-O-acetyl-3 α,12 β,20(*S*),24(*R*)-tetrahydroxydammar-25-en-3-yl hydrogen propanedioate*Betula pendula*[@bib59]**41**12-O-acetyl-3 α,12 β,20(*S*),24(*S*)-tetrahydroxydammar-25-en-3-yl hydrogen propanedionate*Betula pendula*[@bib59]**42**12-O-acetyl-3 α,12 β,17 α,20(*S*),24(*R*)-pentahydroxydammar-25-en-3-yl hydrogen propanedioate*Betula pendula*[@bib59]**Oleanane series43**Oleanolic acid*Betula dahurica*[@bib85], [@bib172], [@bib38], [@bib35], [@bib36], [@bib37], and [@bib80]*Betula ermaniiBetula pendulaBetula platyphyllaBetula schmidtiiBetula utilis***44**Oleanolic acid 3-O-caffeate*Betula dahurica*[@bib38], [@bib39], [@bib36], [@bib37]*Betula ermaniiBetula maximowiczianaBetula schmidtii***45**Acetyl-oleanolic acid*Betula maximowicziana*[@bib35], [@bib39] and [@bib80]*Betula platyphyllaBetula utilis***46**Karachic acid*Betula utilis*[@bib81]**47**Betuloleanolic acid acetate*Betula pendula*[@bib115]**Lupane series48**Betulin*Betula dahurica*[@bib38], [@bib35], [@bib39], [@bib36], [@bib37], [@bib40], [@bib85], [@bib172], [@bib80], and [@bib127]*Betula ermaniiBetula maximowiczianaBetula ovalifoliaBetula pendulaBetula platyphyllaBetula schmidtiiBetula utilis***49**Betulin 3-caffeate*Betula dahurica*[@bib38], [@bib35], [@bib39], [@bib37], [@bib40]*Betula ermaniiBetula maximowiczianaBetula ovalifoliaBetula platyphylla***50**Monogynol A*Betula dahurica*[@bib38], [@bib39], [@bib37]*Betula ermaniiBetula maximowicziana***51**Lupeol*Betula ermanii*[@bib38], [@bib35], [@bib39], [@bib36], [@bib85], and [@bib80]*Betula maximowiczianaBetula pendulaBetula platyphyllaBetula schmidtiiBetula utilis***52**Lupeol caffeate*Betula ermanii*[@bib38]**53**Lupane-3β,20,28-triol 3-O-caffeate*Betula maximowicziana*[@bib39]**54**Betulinic acid*Betula pendula*[@bib85], [@bib35], and [@bib127]*Betula platyphyllaBetula utilis***55**Betulone*Betula schmidtii*[@bib36]**56**Betulonic acid*Betula schmidtii*[@bib36]**Fernane series57**Betufernanediol A*Betula pendula*[@bib115]**58**Betufernanediol B*Betula pendula*[@bib115]Table 3Diarylheptanoids isolated from *Betula* species.NameSpecie from which isolatedReference**Cyclic diarylheptanoids59**Acerogenin E*Betula dahurica*[@bib38], [@bib35], [@bib39], [@bib37]*Betula ermaniiBetula maximowiczianaBetula platyphylla***60**16-hydroxy-17-O-methylacerogenin E*Betula maximowicziana*[@bib39]**61**17-O-methyl-7-oxoacerogenin E*Betula dahurica*[@bib37]**62**15-methoxy-17-O-methyl-7-oxoacerogenin E*Betula dahurica*[@bib37]**63**Alnusdiol β-[d]{.smallcaps}-glucopyranoside*Betula maximowicziana*[@bib39]**Acyclic diarylheptanoids64**Papyriferoside A*Betula papyrifera*[@bib113]**65**5-O-β-[d]{.smallcaps}-apiofuranosyl-(1→2)-β-[d]{.smallcaps}-glucopyranosyl-1,7-bis-(4-hydroxyphenyl)-heptan-3-one*Betula papyrifera*[@bib113]**66**Platyphylloside*Betula papyrifera*[@bib113]**67**Aceroside VII*Betula papyrifera*[@bib113] and [@bib35]*Betula platyphylla***68**Aceroside VIII*Betula platyphylla*[@bib35]**69**1,7-bis-(4-hydroxyphenyl)-4-hepten-3-one*Betula papyrifera*[@bib113] and [@bib35]*Betula platyphylla***70**1,7-bis\[4-hydroxyphenyl\]-3-hepten-5-one*Betula platyphylla*[@bib35]**71**2-hydroxy-1,7-bis\[4-hydroxyphenyl\]-3-hepten-5-one*Betula platyphylla*[@bib35]Table 4Phenylbutanoids isolated from *Betula* species.NameSpecie from which isolatedReference**72**4-(4-hydroxyphenyl)-2-butanol 2-O-β-[d]{.smallcaps}-apiofuranosyl-(1→6)-β-[d]{.smallcaps}-glucopyranoside*Betula ermanii*[@bib38]**73**Rhododendrin(=betuloside)*Betula ovalifolia*[@bib35], [@bib40]*Betula platyphylla***74**Rhododendol (=betuligenol)*Betula platyphylla*[@bib35]**75**3-β-glucopyranosyloxy-1-(4-hydroxyphenyl)-butanone*Betula pendula*[@bib93]**76**(-)-rhododendrol 4′-O-β-[d]{.smallcaps}-glucopyranoside*Betula schmidtii*[@bib36]**77**(-)-rhododendrol 4′-O-α-[l]{.smallcaps}-arabinofuranosyl-(1→6)-β-[d]{.smallcaps}-glucopyranoside*Betula schmidtii*[@bib36]**78**7-{3R-\[(4-hydroxyphenyl)butyl\] β-glucopyranosid-O-6-yl} 4-O-β-glucopyranosylvanillin*Betula pendula*[@bib93]Table 5Phenolics isolated from *Betula* species.NameSpecie from which isolatedReference**79**Methyl syringate*Betula alba*[@bib73]**80**Arbutin*Betula alnoides*[@bib159]**81**3,4,5-trimethoxyphenol β-[d]{.smallcaps}-apiofuranosyl-(1→6)-β-[d]{.smallcaps}-glucopyranoside*Betula dahurica*[@bib38], [@bib39], [@bib37]*Betula ermaniiBetula maximowicziana***82**Chavicol 4-O-α-[l]{.smallcaps}-arabinofuranosyl-(1→6)-β-[d]{.smallcaps}-glucopyranoside*Betula papyrifera*[@bib113]**83**Chavicol 4-O-β-[d]{.smallcaps}-apiofuranoside-(1→6)-β-[d]{.smallcaps}-glucopyranoside*Betula papyrifera*[@bib113]**84**Salidroside*Betula pendula*[@bib157] and [@bib152]**85***p*-coumaric acid*Betula pendula*[@bib134]**86**Ferulic acid*Betula pendula*[@bib134]**87**4-hydroxy-3-methoxyphenyl β-[d]{.smallcaps}-glucopyranoside (=tachioside)*Betula pendula*[@bib152]**88**4-hydroxy-2-methoxyphenyl β-[d]{.smallcaps}-glucopyranoside (=isotachioside)*Betula pendula*[@bib152]Table 6Flavonoids, flavones and flavanones isolated from *Betula* species.NameSpecie from which isolatedReference**Flavonoids89**6-methoxykaempferol*Betula maximowicziana*[@bib39]**90**6-methoxy-3-O-methylkaempferol*Betula maximowicziana*[@bib39]**91**Quercetin*Betula pendula*[@bib119] and [@bib154]*Betula pubescens***92**Myricetin*Betula pendula*[@bib119]**93**Kaempferol*Betula pendula*[@bib119] and [@bib78]*Betula pubescens***94**Rutin*Betula dahurica*[@bib37], [@bib40] and [@bib62]*Betula ovalifoliaBetula humilis***95**Hyperoside (quercetin-3-O-galactoside)*Betula pendula*[@bib16] and [@bib45]**96**Avicularin (quercetin-3-O-arabinoside)*Betula pendula*[@bib16] and [@bib45]**97**Quercitrin (quercetin-3-O-rhamnoside)*Betula pendula*[@bib16]**98**Myricetin 3-O-α-[l]{.smallcaps}-arabinofuranoside*Betula schmidtii*[@bib36]**99**Myricetin 3-O-α-[l]{.smallcaps}-rhamnopyranoside*Betula schmidtii*[@bib36]**100**Myricetin 3-O-β-[d]{.smallcaps}-galactopyranoside*Betula schmidtii*[@bib36]**101**Myricetin-3-digalactoside*Betula verrucosa*[@bib63]*Betula pubescens***102**Kaempferol 3-O-(4-O-acetyl)-α-[l]{.smallcaps}-rhamnopyranoside*Betula platyphylla*[@bib35]**103**Quercetin 3-O-(4-O-acetyl)-α-[l]{.smallcaps}-rhamnopyranoside*Betula platyphylla*[@bib35]**104**Myricetin-3-O-galactoside*Betula pendula*[@bib16] and [@bib45]**105**Quercetin-3-O-glucuronide*Betula pendula*[@bib16] and [@bib45]**106**Kaempfereol-3-O-glucoside*Betula pendula*[@bib45]**107**Kaempfereol-3-O-glucuronide*Betula pendula*[@bib45]**Flavones108**Apigenin*Betula pendula*[@bib119]**109**Acacetin*Betula pendula*[@bib119]**110**4′,6-Dimethoxy-5-hydroxyflavone-7-O-β-[d]{.smallcaps}-glucoside*Betula platyphylla*[@bib90]**Flavanones111**Naringenin*Betula maximowicziana*[@bib39]**112**6-C-glucosylnaringenin*Betula platyphylla*[@bib90]**113**6-C-glucosylaromadendrin*Betula platyphylla*[@bib90]Table 7Catechins and lignana isolated from *Betula* species.NameSpecie from which isolatedReference**Catechins114**(+) catechin*Betula dahurica*[@bib157], [@bib152], [@bib35], [@bib36], [@bib37], [@bib40], [@bib113], and [@bib92]*Betula ovalifoliaBetula papyriferaBetula pendulaBetula platyphyllaBetula schmidtii***115**(+) catechin 7-O-β-[d]{.smallcaps}-xylopyranoside*Betula dahurica*[@bib38], [@bib35], [@bib39], [@bib37], [@bib40], [@bib152], and [@bib113]*Betula ermaniiBetula maximowiczianaBetula ovalifoliaBetula papyriferaBetula pendulaBetula platyphylla***116**Epicatechin*Betula platyphylla*[@bib92]**117**Procyanidin B-3*Betula ovalifolia*[@bib40]**Lignans118**(-)-lyoniresinol 3α-O-β-[d]{.smallcaps}-xylopyranoside (=nudiposide)*Betula dahurica*[@bib38], [@bib36], [@bib37] and [@bib113]*Betula ermaniiBetula papyriferaBetula schmidtii***119**(-)-isolarisiresinol 3α-O-β-[d]{.smallcaps}-xylopyranoside*Betula pendula*[@bib152]**120**(+)-lyoniresinol 3α-O-α-[l]{.smallcaps}-rhamnopyranoside*Betula ermanii*[@bib38], [@bib39]*Betula maximowicziana***121**(+)-lyoniresinol 3α-O-β-[d]{.smallcaps}-glucopyranoside*Betula schmidtii*[@bib36]**122**(+)-lyoniresinol 3α-O-β-[d]{.smallcaps}-xylopyranoside (=lyoniside)*Betula pendula*[@bib152]Table 8Steroids and miscellaneous compounds isolated from *Betula* species.NameSpecie from which isolatedReference**123**(3R)-3,5′-dihydroxy-4′-methoxy-3′,4″-oxo-1,7-diphenyl-1-heptene*Betula dahurica*[@bib35], [@bib36], [@bib37], [@bib40]*Betula ovalifoliaBetula platyphyllaBetula schmidtii***124**9,9′-di-O-feruloyl-(-)-secoisolariciresinol*Betula ermanii*[@bib38]**125**Ovalifoliolide A*Betula ovalifolia*[@bib40]**126**Ovalifoliolide B*Betula ovalifolia*[@bib40]**127**Caryophyllene oxide*Betula platyphylla*[@bib35]**128**(2R,3R)-2,3-dihydro-3-hydroxymethyl-7-methoxy-2-(3′-methoxy-4′-α-[l]{.smallcaps}-rhamnopyranosyloxyphenyl)-5-benzofuranpropanol*Betula pendula*[@bib152]**129**\[12β-acetoxy-4,4,8,10,14-pentamethyl-17-(2-methyl-5-oxotetrahydrofuran2(S)-yl)-hexadecahydrocyclopenta\[a\]phenanthren-3α-yl\] hydrogen propanedioate*Betula pendula*[@bib59]**130**7α-hydroxy-β-sitosterol*Betula platyphylla*[@bib35]**131**7β-hydroxy-β-sitosterol*Betula platyphylla*[@bib35]**132**β-sitosterol*Betula utilis*[@bib80]**133**Stigmast-4-ene-3-one*Betula platyphylla*[@bib35]**134**Platyphyllin A*Betula platyphylla*[@bib166]**135**Methyl (12R,20S)-20-hydroxy-12-β-[d]{.smallcaps}-xylopyranosyloxy-3,4-secodammara-4(28),24-dien-3-oate (betula-schmidtoside A)*Betula schmidtii*[@bib36]**136**Hydroxyhopanone*Betula platyphylla*[@bib35]**137**Benzyl alcohol β-[d]{.smallcaps}-apiofuranosyl-(1→6)-β-[d]{.smallcaps}-glucopyranoside*Betula maximowicziana*[@bib39]

Phytochemical investigations revealed that the triterpenoids, generally present in the leaves and bark of the *Betula* species, belong mainly to the ocotillol and dammarane type of triterpenoids ([Fig. 2](#f0010){ref-type="fig"}, [Table 2](#t0010){ref-type="table"}). Several of them are esterified with malonic acid and caffeic acid at C-3 position. Other reperted triterpenoids belong mainly to the oleanane, lupane and fernane series. Betulin **(48)** and betulinic acid **(54),** belonging to the lupane series, are two important triterpenoids present in *Betula* species. Diarylheptanoids, both cyclic and acyclic ([Fig. 3](#f0015){ref-type="fig"}, [Table 3](#t0015){ref-type="table"}), phenylbutanoids ([Fig. 4](#f0020){ref-type="fig"}, [Table 4](#t0020){ref-type="table"}) and other phenolics ([Fig. 5](#f0025){ref-type="fig"}, [Table 5](#t0025){ref-type="table"}) form the other major groups of compounds present and are found to occur mainly in the leaves. Platyphylloside **(66)** is a diarylheptanoid glycoside that has been isolated and identified. Presence of flavonoids ([Fig. 6](#f0030){ref-type="fig"}, [Table 6](#t0030){ref-type="table"}) and catechins and lignans ([Fig. 7](#f0035){ref-type="fig"}, [Table 7](#t0035){ref-type="table"}) is a regular feature. A few steroids and other compounds ([Fig. 8](#f0040){ref-type="fig"}, [Table 8](#t0040){ref-type="table"}) have also been reported.

Besides these, [@bib23] analyzed the essential oil of *Betula pendula* buds and identified more than 50 compounds. The main components found were α-copaene, germacrene D and δ-cadinene. The major components of the volatile oil from the inner bark of *Betula pendula* were trans α-bergamotene and α-santalene ([@bib168]). Tea infusion of *Betula pendula*, which is used in herbal teas in Europe, was analyzed for the occurrence and content of quercetin and rutin and other minor biologically active compounds ([@bib21]).

Procyanidin glycosides, that are still rarely found in nature, were isolated from the bark of *Betula pendula* by [@bib94]. The polymeric proanthocyanidins in the birch leaves were determined by [@bib76]. [@bib84] determined the amino acid composition of *Betula pendula* leaves. [@bib136], [@bib135], [@bib137] have worked extensively on the hydrolysable tannins of *Betula*. [@bib132] made a comparative study of the triterpenes of *Betula pendula* and *Betula pubescens.* [@bib131] have reported hemolytic dammarane triterpenoid esters from *Betula pendula*. [@bib151] have reported the presence of several arylbutanoid and diarylheptanoid glycosides in *Betula pendula*. [@bib14] employed modern techniques such as FT-Raman and FT-IR spectroscopy in conjunction with GC--MS to characterize the raw bark and natural extract products obtained from the *Betula* species and to evaluate their potential to directly identify the main active compounds from birch bark natural extract products.

Chemotaxonomic and ecological studies have been carried out using rhododendrin, platyphylloside, phenolics and flavonoids ([@bib139], [@bib140], [@bib100], [@bib163], [@bib164], [@bib150], [@bib88], [@bib154], [@bib109], [@bib114], [@bib95]).

5. Pharmacological activity {#s0025}
===========================

The varied ethnomedicinal uses of the different species of *Betula* have led to the initiation of many pharmacological investigations. Previous research demonstrates that the *Betula* species exhibit a wide range of biological activities, such as anticancer, anti-inflammatory and immunomodulatory and others like antioxidant, antidiabetic, antiviral and antiarthritic activities. An overview of the modern pharmacological evaluations carried out on these species has been described in greater detail in the following sections.

5.1. Anticancer {#s0030}
---------------

Different *Betula* species were subjected to varied experiments and assays in order to determine their anticancer activity. The different human as well as murine cell lines against which the cytotoxicity studies have been conducted have been listed in [Table 9](#t0045){ref-type="table"}.Table 9Cell lines used for cytotoxicity studies.**Cell lineOrigin tissueReference**A2780Human ovarian carcinoma[@bib22]A431Human skin epidermoid carcinoma[@bib22] and [@bib153]A-549Human lung carcinoma[@bib113]DLD-1Human colorectal adenocarcinoma[@bib113]HeLaHuman cervix adenocarcinoma[@bib22] and [@bib153]HL-60Human promyelocytic leukemia cells[@bib75]K562/AdrHuman multidrug-resistant cancer cells, resistant to adriamycin[@bib77]KB-C2Human multidrug-resistant cancer cells[@bib77] and [@bib171]MCF7Human breast adenocarcinoma[@bib22] and [@bib153]ATCC L1210Mouse lymphocytic leukemia cells[@bib51]HSC-T6Rat liver stellate cells[@bib89]V79-4Chinese hamster lung fibroblast cells[@bib75]

The leaves and buds of *Betula pubescens (Betula alba)* have been reported to be used for the treatment of cancer of the uterus ([@bib9]).

The methylene chloride as well as the methanol extracts of *Betula pendula* were evaluated for the activity against leukemia and thrombin ([@bib51]). A cytotoxicity assay was used with L1210 as target cells. This assay determines the inhibitory effect of test samples on the growth of mouse leukemia cells (ATCC L1210). The extracts exhibited 99% and 91% activity respectively at 10 mg per well concentration of the extract. They however exhibited only 15% and 7% antithrombin activity respectively when compared with the blank solution. Antiproliferative activity of *Betula pendula* was also studied on B16 melanoma cells ([@bib15]). [@bib153] studied the antiproliferative effects of *Betula pendula* bark and its two major compounds betulin **(48)** and betulinic acid **(54)** *in vitro* on three human cell lines: HeLa (cervix adenocarcinoma), MCF7 (breast adenocarcinoma) and A431 (skin epidermoid carcinoma), using the MTT (\[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\]) assay. They were found to possess antiproliferative activities, as is also suggested in the literature against other tumoural cell lines ([@bib42], [@bib25]). Although the birch bark extract presented antiproliferative activity, it was not very different to the main compound in its composition, betulin. They could both be considered important therapeutic compounds for skin pathology but also for other types of hyperproliferative pathologies, including other solid cancers. Although the exact IC~50~ values were not determined, the results revealed considerable efficacies of both the extract and its active components against A431 and HeLa cell lines. The concentration range in which the proliferation of skin cancer cells was substantially inhibited (approximately 70--80%) may present practical significance, especially in the case of local administration. The *in vitro* data suggested the high efficiency of betulinic acid and also of the related compound betulin as anticancerous agents, but further that the exploitation of their natural source, birch bark extract, could prove to be very useful. Betulin enriched extracts of the bark of *Betula pendula*, containing over 90% betulin, were also tested for their growth inhibiting effects *in vitro* on four malignant human cell lines: A431 (skin epidermoid carcinoma), A2780 (ovarian carcinoma), HeLa (cervix adenocarcinoma) and MCF7 (breast adenocarcinoma), by means of MTT assay ([@bib22]). All of the prepared bark extracts exerted a pronounced antiproliferative effect against human cancer cell lines. The goal of the MTT assay was a direct comparison of the extracts, concluding that the IC~50~ values of all the samples was between 1 and 5 μg/mL. The substantial differences in betulin and betulinic acid content of the extracts were not reflected in the antiproliferative activities. The reason of this contradiction could be the presence of other active natural compounds in birch bark, including flavonoids.

[@bib113] carried out *in vitro* investigations on the methanolic extract of the inner bark of *Betula papyrifera* and found it to exert a cytotoxic activity against human lung carcinoma (A-549; IC~50~, 104±3 µg/mL) and colorectal adenocarcinoma (DLD-1; IC~50~, 79±2 µg/mL) cell lines. The bioassay-guided fractionation of the crude extract led to the isolation of 10 phenolic compounds including diarylheptanoid glycosides, a diarylheptanoid, a lignan and flavonoids. *In vitro* cytotoxic activities of the isolated compounds were assessed against lung carcinoma (A-549) and colorectal adenocarcinoma (DLD-1) human cell lines, as well as against human normal skin fibroblasts (WS1) using the resazurin reduction test. Among the isolated compounds, platyphylloside **(66)**, a diarylheptanoid glycoside, exerted the most potent cytotoxic activity (IC~50~, 10.3--13.8 µM), showing stronger activity than 5-fluorouracil towards the DLD-1 cell line. In addition, a diarylheptanoid and 2 other diarylheptanoid glycosides displayed moderate cytotoxicities against all tested cell lines. The other compounds did not exhibit any significant *in vitro* cytotoxicity against tested cancer cell lines.

Extracts of birch bark were also tested in actinic keratosis. The most important pathogenetic factor in the development of actinic keratoses is ultraviolet B (UVB) radiation. Mutations in keratinocytes caused by UVB radiation lead to abnormal cell proliferation and disturbed repair of gene defects and also interfere with apoptosis by inactivating protein p53. Actinic keratoses are considered an initial, still non-invasive form of squamous cell carcinoma. A pilot study using a standardized birch bark ointment was performed. Treatment response was assessed clinically after 2 months. The standardized birch bark extract was found to be effective in the treatment of actinic keratoses and had no side effects. This birch bark ointment may be a new therapeutic option for actinic keratoses ([@bib69]).

Studies were carried out to investigate whether *Betula platyphylla* var. *japonica* inhibits H~2~O~2~-induced oxidative stress in Chinese hamster lung fibroblast (V79-4) cells and to characterize the mechanism of its anticancer effects in human promyelocytic leukemia (HL-60) cells. It was observed that the total methanol extract of *Betula platyphylla* had protective effects against hydrogen peroxide (H~2~O~2~) in the Chinese hamster lung fibroblast (V79-4) cell line and induced apoptotic cell death in human promyelocytic leukemia (HL-60) cell line. It significantly increased cell viability against H~2~O~2~ induced oxidative stress. The extract reduced the number of V79-4 cells arrested in G2/M in response to H~2~O~2~ treatment. Treatment with the extract induced cytotoxicity and apoptosis in HL-60 cells, as shown by nucleosomal DNA fragmentation, increases in the subdiploid cell population, and fluorescence microscopy. It gradually increased the expression of pro-apoptotic Bax and led to the activation of caspase-3 and cleavage of PARP. The findings suggested that *Betula platyphylla* var. *japonica* exhibits potential anticancer properties ([@bib75]).

Bioassay-guided fractionation and repeated chromatography of the methanol extract of the floral spikes of *Betula platyphylla* var. *japonica* led to the isolation of 20 triterpenoids. The cytotoxicity of the isolated triterpenes against human cancer cell lines as well as multidrug-resistant cancer cell lines was evaluated. Most of the isolated triterpenes showed very weak cellular toxicities. Although no discernible differences were found in the cytotoxicities for the tested compounds against sensitive and resistant cell lines, the cytotoxicities for several triterpenes against multidrug-resistant cancer cell lines (KB-C2 or K562/Adr) were enhanced in the presence of nontoxic concentrations of colchicine or doxorubicin ([@bib77]). Since one of the major causes of multidrug resistance (MDR) in cancer cells is over-expression of P-glycoprotein (P-gp), the MDR reversing activity might be involved in inhibition of P-gp ATPase ([@bib143]).

5.2. Antiinflammatory {#s0035}
---------------------

A number of extracts from *Betula* species have shown anti-inflammatory activity in different test models. [@bib162] tested the aqueous extract of the leaves of *Betula pendula* for anti-inflammatory activity using isolated cells and enzymatic tests *in vitro*. It was evaluated for inhibitory activity on prostaglandin biosynthesis and platelet activating factor (PAF)-induced exocytosis *in vitro* at a concentration of 0.2 mg/mL and 0.25 mg/mL respectively. The leaves exhibited 23±2% prostaglandin synthesis inhibition and 76[+]{.ul}4% PAF-exocytosis inhibition. The effects shown by the extracts of the leaves of *Betula pendula* might be explained by the high contents of tannins and other kinds of polyphenols. Several hemolytic compounds of dammarane type that have been isolated from the leaves of *Betula pendula* might affect the neutrophils in the PAF-test and thus influence the result. Later, [@bib165] demonstrated the effect of *Betula pendula* leaf extract (BPE) on corneal inflammation following keratoplasty in the rat model. T cells were stimulated *in vitro* in the presence of BPE. Proliferation, activation phenotype and the number of apoptotic/necrotic cells in cell culture were analyzed by flow cytometry. Corneal transplantation was performed between Fisher and Lewis rats. Recipient rats were either treated with cyclosporine A at a low dosage (Low-dose CsA=LDCsA) or received LDCsA in combination with BPE (2×1 ml/day). Clinical signs for corneal inflammation and rejection time points were determined. Infiltrating leukocytes were analyzed histologically. BPE specifically inhibited T cell proliferation *in vitro* by inducing apoptosis. The phenotype was not affected. *In vivo*, BPE significantly delayed the onset of corneal opacification (*p*\<0.05). The amount of infiltrating CD45(+) leukocytes and CD4(+) T cells (*p*\<0.001) was significantly reduced by BPE, whereas infiltration of CD163(+) macrophages was not significantly different between the two groups. BPE selectively induces apoptosis of activated T cells. Accordingly, BPE treatment significantly reduces infiltrating T cells and subsequent corneal opacification following keratoplasty. The findings suggest BPE as a promising anti-inflammatory drug to treat corneal inflammation. [@bib22] conducted *in vivo* studies involving the anti-inflammatory effect of *Betula pendula* extracts on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced model of inflammation in mice. It is well known that in a few hours application of 12-O-tetradecanoylphorbol-13-acetate (TPA) can induce an inflammatory process to mouse ears by increasing vascular permeability, producing edema and swelling inside dermis. Indometacin was used as reference. Both betulin and ethanolic extracts (1 pp and 3 pp) were used to determine the reduction of edema. Betulin was found to be comparable with indometacin; however, the extracts revealed the most intense anti-inflammatory potential probably because of the aggregation of effects of other triterpenes, also present in the extract composition, even in small concentrations (betulinic acid, lupeol *etc.*).

The anti-inflammatory activity of *Betula alnoides* extract was evaluated in acute and subacute inflammation models. The extract was also evaluated for antiinflammatory activity in sheep RBC induced sensitivity and in membrane stabilization models ([@bib155]). The inhibitory percentage of the extract was high 40.7% at a dose of 100 mg/kg and increased in a dose dependent manner, on carrageenan induced paw edema in mice. The inhibitory percentage of the extract on granuloma tissue formation was 29.7% at a dose of 100 mg/kg and 47.63% at a dose of 200 mg/kg. Although the extract was not statistically significant on sheep RBC-induced sensitivity, the inhibitory percentage on the rabbit membrane lysis was high; 56.25+2.29 at a concentration of 250 µg/mL and increased to 72.19+3.18 at a concentration of 500 µg/mL.

The inhibitors of prostaglandin biosynthesis and nitric oxide production have been considered as potential anti-inflammatory and cancer chemopreventive agents ([@bib60]). Methanolic extract of the cork of *Betula platyphylla* was screened for its inhibitory effect on prostaglandin biosynthesis and nitric oxide production in LPS-stimulated RAW264.7 cell, a murine macrophage cell line at the test concentration of 10 µg/mL. However only 25.9% inhibition of COX-2 activity was observed.

5.3. Arthritis and rheumatism {#s0040}
-----------------------------

One of the prominent uses of *Betula* species in traditional medicine is against arthritis and rheumatism. Several studies have been carried out to support these claims. *In vitro* xanthine oxidase inhibitory properties of plants traditionally used in Czech Republic and Central-East Europe region for gout, arthritis or rheumatism treatment were studied by [@bib57]. Since gouty arthritis or uric acid nephrolithiasis is a result of marked hyperuricemia, leading to the deposition of monosodium urate crystals in joints or kidneys, the enzyme xanthine oxidase is a possible target for urate-lowering drugs in humans and is used predominately in hypouricemic therapy. *Betula pendula* and *Populus nigra* were identified as species with the highest xanthine oxidase inhibitory potential in the study. The 80% ethanolic and methylene chloride--methanolic extracts of *Betula pendula* exhibited IC~50~ values of 39.4 and 25.9 µg/mL, respectively. *Betula pendula* was among the most active supposedly because of the content of salicylates or other phenolics. In another study ([@bib52]), *in vitro* experiments were conducted to investigate the influence of the extract of *Betula pendula* on primary human lymphocytes in comparison to the synthetic anti-arthritis drug methotrexate. Lymphocyte proliferation and cell division were measured by the activity of mitochondrial dehydrogenases and by using the membrane-permeable dye carboxyfluorescein diacetate succinimidyl ester (CFSE), respectively. Apoptosis was analyzed by surface staining of phosphatidylserine and intracellular activation of effector caspases 3 and 7 in comparison to the drug methotrexate using flow cytometric and photometrical analysis. In addition, the impact of the extract on cell cycle distribution was investigated by propidium iodide staining of DNA. For the bioassays BPE concentrations of 10--160 µg/mL were investigated. Leaf extracts of *Betula pendula* inhibited the growth and cell division (CD8^+^: 40 µg/mL: 45%; 80 µg/mL: 60%; 160 µg/mL: 87%) (CD^+^: 40 µg/mL: 33%; 80 µg/mL: 54%; 160 µg/mL: 79%) of activated, but not of resting T lymphocytes in a significant dose-dependent manner. The inhibition of lymphocyte proliferation due to apoptosis induction (compared to untreated control: 40 µg/mL: 163%; 80 µg/mL: 240%; 160 µg/mL: 348%) and cell cycle arrest was comparable to that of methotrexate. It is known that peripheral blood lymphocytes play an important role in the perpetuation of the autoimmune processes in rheumatoid arthritis and the maintenance of these cells might be caused by the dysregulation of proliferation and apoptosis. The study, thus, gave a rational basis for the use of *Betula pendula* leaf extract for the treatment of immune disorders, like rheumatoid arthritis, by diminishing proliferating inflammatory lymphocytes

Osteoarthritis is a degenerative joint disease characterized by the progressive loss of articular cartilage, subchondral bond remodeling, spur formation, synovial inflammation and the degradation of proteoglycan and collagen. The integrity of these macromolecules is vital to cartilage and joint function. [@bib18] investigated the cartilage protective effects and mechanism of *Betula platyphylla* on rabbit articular cartilage. It was observed that the bark extract of *Betula platyphylla* inhibited the degradation of proteoglycan and collagen through the down regulation of MMP-3 and MMP-13 expressions and activities without affecting the viability or morphology of IL-1α-stimulated rabbit articular cartilage explants. The n-butanol fraction from the bark of *Betula platyphylla* (BFBP) was identified as the most potent cartilage protective fraction. It was shown to have protective effects against cartilage degradation in a collagenase-induced osteoarthritis rabbit model ([@bib67]). Oral administration of BFBP dose-dependently suppressed the stiffness and global histologic score. The proteoglycan content was considerably increased in a dose-dependent manner in the BFBP treated group. The mRNA expression of MMP-1 and MMP-3 was also decreased. On the contrary, the level of TIMP-1 in the synovial fluids was significantly increased in the BFBP treated group. The pathologic inflammatory molecules such as PGE2 and COX-2 were inhibited by BFBP, but COX-1 expression was not affected. It was, therefore, suggested that BFBP showed the protective effect on cartilage alternations through balance of MMPs/TIMP-1. BFBP is a COX-2 inhibitor through suppressing the production of PGE2 and inhibiting of expression of COX-2 in CIA. It regulated inflammatory-related molecules in *in vivo* model of OA. [@bib68] also investigated the inhibitory effects of *Betula platyphylla* in IL-1β-stimulated rheumatoid arthritis fibroblast-like synoviocytes derived from patients with rheumatoid arthritis. The anti-nociceptive and anti-inflammatory efficacy was compared to celecoxib, a selective COX-2 inhibitor, in animal models of arthritis. *Betula platyphylla* significantly inhibited proliferation of IL-1β-induced synoviocytes. It reduced the levels of inflammatory mediators, such as IL-6, TNF-α, MMP-1, MMP13, and PGE2. The release of nitrites and iNOS, as well as release of NF-κB, into the nucleus of IL-1β-treated synoviocytes was significantly inhibited, even at concentrations as low as 1 µg/mL. Oral administrant of *Betula platyphylla* at 400 mg/kg significantly decreased about 27.8% of tail flick withdrawal and inhibited the number of paw flinches in both phases 1 and 2 of the formalin test. In the carrageenan-induced acute pain and arthritis model, *Betula platyphylla* dose dependently reduced the nociceptive threshold and the arthritic symptoms at day 8, respectively. At 400 mg/kg, it markedly reduced the inflammatory area about 48% in the ankle joints. This capacity of *Betula platyphylla* at 400 mg/kg was similar to that of the celecoxib-2 inhibitor in carrageenan-induced nociceptive and inflammatory arthritis model. These results suggested that *Betula platyphylla* has anti-nociceptive and anti-inflammatory effects in IL-1β-stimulated RA FLS and in an animal model of arthritis.

5.4. Antioxidant {#s0045}
----------------

Various *Betula* extracts were thus investigated for their free radical scavenging activities. *Betula pendula* was sequentially percolated with five solvents of increasing polarities (hexane, chloroform, ethyl acetate, methanol, and water). These were screened for antioxidant activity. The free radical scavenging activities were examined in different systems using electron spin resonance (ESR) spectroscopy. These assays were based on the stable free radical DPPH, the hydroxyl radicals generated by a Fenton reaction, and the superoxide radicals generated by the X/XO system. It possessed high antioxidant activities for the most polar fractions ([@bib15]).

The total methanol extract of *Betula platyphylla* var. *japonica* exhibited protective effects against hydrogen peroxide (H~2~O~2~) in the Chinese hamster lung fibroblast (V79-4) cell line. The extract also showed high DPPH radical scavenging activity (IC~50~ 2.4 µg/ml) and lipid peroxidation inhibitory activity (IC~50~ below 4.0 µg/mL). Furthermore, the extract increased the activities of several cellular antioxidant enzymes, including superoxide dismutase, catalase and glutathione peroxidase ([@bib75]).

[@bib49] investigated the 80% methanolic extract of *Betula alnoides* and its sub-fractions for antioxidant activities by using antioxidant tests, including electron donation ability test, reducing power, and metal-chelating activity assay. The results showed that 80% methanolic extracts exhibited high DPPH scavenging activity (80.68%). In addition, both the 80% methanolic extract and EtOAc fraction exhibited more potent reducing activity than did butylated hydroxyanisole (BHA) and trolox. The aqueous fraction had higher metal-chelating activity than other fractions. The EtOAc fraction had the highest phenolic and flavonoid content (217.73±1.02 mg GAE/g extract, and 38.42±1.87 mg QE/g extract, respectively).

5.5. Antimicrobial and antiviral {#s0050}
--------------------------------

A number of extracts from *Betula* species have demonstrated antibacterial, antifungal and antiviral activities against numerous pathogenic strains. [@bib74] noted that the ethanolic extract of *Betula allegheniensis* showed activity against *Saccharomyces cerevisiae* while [@bib167] observed that *Betula alleghaniensis* showed a significant degree of activity against many of the yeast isolates. It had the strongest activity against *Saccharomyces cerevisiae*, with activity observed at 200 mg/mL at 72 h. White birch (*Betula pubescens*) was found to be active against gram-positive *Staphylococcus aureus* ([@bib129]). The 80% methanolic extract of *Betula alnoides* and its sub-fractions were investigated for antioxidant and antimicrobial activities. The 80% methanolic extract and EtOAc fraction showed higher levels of antimicrobial activity than did other fractions ([@bib49]).

The ethanolic extract of the wood and bark of *Betula papyrifera* along with 13 other eastern North American hardwood tree species was screened for antimicrobial activity against eight strains of bacteria and six strains of fungi ([@bib120]). Bacterial strains tested included the gram positive strains: *Staphylococcus aureus* methicillin-sensitive, *Enterococcus faecalis*, *Mycobacterium phlei*, *Bacillus subtilus*, and the gram negative strains: *Eschericia coli* wild strain, *Pseudomonas aeruginosa* 187 (wild). *Staphylococcus aureus* causes serious food intoxication; *Enterococcus faecalis*, *Salmonella typhimurium*, *Eschericia coli*, *Bacillus subtilus*, *Pseudomonas aeruginosa* 187 (wild), and *Mycobacterium phlei* cause food spoilage and human infection whereas the toxin from *Klebsiella pneumonia* is known for fish poisoning. The fungal strains used in this study were opportunistic pathogens of humans except for *Saccharomyces cerevisiae. Cryptococcus neoformans* causes generalized mycosis with a predilection for the central nervous system, *Candida albicans* causes oral thrush and systemic infections, *Aspergillus fumigatus* may be associated with respiratory infections and *Microsporum gypseum* and *Trichophyton mentagrophytes* are dermatophytes. The bark extract was found to be active against *Staphylococcus aureus* (methicillin-sensitive). When tested against *Bacillus subtilus*, *Enterococcu faecalis*, *Mycobacterium phlei*, the bark extract showed zones of growth inhibition.

The methanolic extracts obtained from external and internal bark, flowers, leaves and buds of *Betula pendula* were also evaluated for their antibacterial activity. Triterpene compounds, betulin, betulinic acid, oleanolic acid and lupeol, isolated from the external parts of birch bark, were also investigated for their antibacterial activity against selected Gram-positive bacteria, *Bacillus subtilis*, *Staphylococcus aureus* and Gram-negative bacteria, *Escherichia coli* and *Pseudomonas aeruginosa.* The most prominent antibacterial activity was shown by oleanolic acid against bacterial species *Staphylococcus aureus* and *Bacillus subtilis* while *Escherichia coli* showed resistance on all investigated samples ([@bib27]).

Antibacterial activity of aqueous extracts and solvent extracts of *Betula utilis* bark was determined by a cup diffusion method on nutrient agar medium against 14 important human pathogenic bacterial cultures. The methanol and ethanol extracts recorded antibacterial activity against all the test pathogens ([@bib87]).

Methanolic plant extract of *Betula papyrifera* was screened for antiviral activity against seven viruses *viz.* bovine coronavirus (BCV, Coronaviridae), bovine herpesvirus type 1 (BHVl, Herpesviridae), bovine parainfluenza virus type 3 (BP13, Paramyxoviridae), bovine rotavirus (BRV, Reoviridae), bovine respiratory syncytial virus (BRSV, Paramyxoviriaize), vaccinia virus (Poxviridae) and vesicular stomatitis virus (VSV, Rhabdoviridae). However no significant activity was observed ([@bib106]).

5.6. Dermatological uses {#s0055}
------------------------

[@bib82] investigated if and how the extract of the bark of *Betula platyphylla* Sukat. var. *japonica* Hara (Asian white birch, AWB) inhibited the development of atopic dermatitis (AD) like skin lesions in NC/Nga mice, which is a recently recognized murine model of AD. The skin symptom severity, itching behavior, serum IgE level and mRNA expression of the cytokines at lymph node in the mice were examined. The hapten-induced dermatitis model was used in this study since repeated hapten (picryl chloride; PC) treatment causes apparent dermatitis in 100% of NC/Nga mice. Oral administration of AWB extracts (25, 100 and 250 mg/kg) to the PC-treated mice inhibited the development of AD-like skin lesions as exemplified by a significant decrease in the total skin severity scores, itching behavior and a decrease in hypertrophy and infiltration of inflammatory cells into dermis. The serum IgE level was also significantly reduced by AWB extract. In the RT-PCR results, the expression of interleukin-4 mRNA was reduced by AWB extract, whereas the expression of interferon-γ mRNA was not changed. These results suggest that AWB inhibits the development of AD-like skin lesions in NC/Nga mice through the suppression of the T(H)2 cell response. Besides, [@bib118] carried out *in vitro* and *in vivo* studies to elucidate whether and how *Betula platyphylla* modulated the mast cell-mediated allergy inflammation. Pharmacological effects of *Betula platyphylla* on both compound 48/80 or histamine-induced scratching behaviors and 2,4-dinitrochlrobenzene (DNCB)-induced atopic dermatitis in mice were ascertained. Additionally, to find a possible explanation for the anti-inflammatory effects of *Betula platyphylla*, the effects of *Betula platyphylla* on the release of histamine in compound 48/80-induced rat peritoneal mast cells (RPMCs), production of inflammatory mediators and activation of nuclear factor-κB (NF-κB) and caspase-1 in phorbol 12-myristate 13-acetate plus calcium ionophore A23187 (PMACI)-stimulated human mast cells (HMC-1) were also evaluated. The finding of this study demonstrated that *Betula platyphylla* reduced compound 48/80 or histamine-induced scratching behaviors and DNFB-induced atopic dermatitis in mice. Additionally, it also inhibited the release of histamine in RPMC and production of inflammatory cytokines as well as the activation of NF-κB and caspase-1 in stimulated HMC-1. Collectively, the findings of this study provided novel insights into the pharmacological actions of *Betula platyphylla* as a potential molecule for use in the treatment of allergic inflammatory diseases.

Reports show that North American natives made extensive use of barks and resins from trees for treating dermatological conditions. Studies were thus carried out to evaluate the antioxidant activities of ethanolic and hot water extracts from barks of Canadian wood species, their toxicological effects on normal human keratinocytes and the antiproliferative properties of these extracts on the growth of normal, lesional and non-lesional psoriatic keratinocytes. These properties of crude extracts from barks of Canadian species were also compared with those of the standardized French maritime pine bark extract (Oligopin^®^) ([@bib43]). The results showed that yellow birch (*Betula alleghalensis*) extract obtained by maceration had high antioxidant capacity. Also, that after 24 h the initial toxicities of YB~Mac~ and Oligopin^®^ determined by the TBDE method are comparable. After 48 h, the initial toxicity of YB~Mac~ did not significantly vary and Oligopin^®^ showed to be less toxic. IC~90~ values determined by the TBDE method after 24 h showed an inverse correlation with the content of CinnAc (*r*=−0.73; *p*=0.0246) and PAs (*r*=−0.66; *p*=0.049) whereas after 48 h no correlations could be determined between IC~90~ and the different classes of phenolic compounds. Toxicity of extracts on keratinocyte plasma membrane and mitochondria after 24 h was attributed to their content of hydroxycinnamic acids and proanthocyanidins. The mean degree of polymerization of proanthocyanidins (DPm) of crude extract from barks of *Betula* spp. is reported to be 6.4. Thus, it could be hypothesized that the higher degree of polymerization of YB~Mac~ proanthocyanidines and the presence of terpenic compounds in this extract, which can be extracted with ethanol at high concentrations ([@bib24]), could influence on the higher initial toxicity observed on keratinocytes plasma membrane after 24 h. The crude extracts from bark of Canadian wood species and Oligopin^®^ presented a modest inhibition on the growth of normal and psoriatic keratinocytes, but were not selective for lesional psoriatic cells after exposure during 48 h. YB~Mac~ at 90 µg/mL was shown to inhibit by 26% the NHK growth, but it failed to induce any change in lesional and nonlesional PK growth. These studies demonstrated the toxicological and antiproliferative properties of polyphenolic extracts from barks of yellow birch as well as other Canadian species on normal and psoriatic keratinocytes.

It has been observed that with a recently developed triterpene extract from the outer bark of *Betula pubescens* syn*. Betula alba*, with over 80% betulin, a cream can be produced without the aid of emulsifiers. It only consists of 4.5% (v/v) birch bark extract, vegetable oil and water. In an artificially damaged skin barrier, a comparable or even superior effect of the birch bark cream with respect to improvement in stratum corneum hydration, reduction of TEWL and skin erythema as opposed to 'hydrophilic cream NRF' (consisting of nonionic emulsifying alcohols, 2-ethylhexyllauromyristate, glycerol, potassium sorbate, citric acid and water) was seen. *In vitro*, birch bark extract increased calcium influx into primary keratinocytes and upregulated various differentiation markers including keratin-10 and involucrin. Topical treatment with an oleogel containing 10% (v/v) birch bark extract of actinic keratosis, which represent *in situ* squamous cell carcinomas with disturbed epithelial differentiation, resulted in upregulation of keratin-10 *in situ*. Thus, bark displays skin-barrier-reinforcing properties that may be used in dermocosmetics for dry skin ([@bib17]).

Birch leaves extracts are included in many skin cosmetic products. The potential ability of *Betula pendula* leaves ethanolic extract (BE) for the development of skin whitening agents was evaluated on mushroom tyrosinase activity ([@bib46]). Results showed that BE was capable of inhibiting, dose-dependently, [l]{.smallcaps}-DOPA oxidation catalyzed by tyrosinase. The inhibition kinetics, analyzed by Lineweaver-Burk plots, showed a noncompetitive inhibition of BE towards the enzyme, using [l]{.smallcaps}-DOPA as substrate. The inhibitory mechanism of BE as studied by spectrophotometric analysis, demonstrated its ability to chelate copper ion in the active site of tyrosinase. In addition, BE exhibited Fe(2+)-chelating ability (IC~50~ 614.12±2.14 μg/mL), reducing power and radical-scavenging properties (IC~50~ 137.22±1.98 μg/mL). These results suggest the usefulness of birch leaves extracts in cosmetic and pharmaceutical industries for their skin-whitening and antioxidant effects.

5.7. Immunoregulatory {#s0060}
---------------------

Studies have shown that birch bark extracts can have immunoregulatory effects. The effects of birch bark from *Betula pubescens* on immune system were studied by [@bib34]. Human monocyte-derived dendritic cells (DCs) were matured with or without dried *Betula* bark ethanolic extract (DBBEE) or its fractions I--V at several concentrations. The effects of the extract and fractions on DC maturation were determined by measuring cytokine secretion by ELISA and expression of surface molecules by flow cytometry. DBBEE and fractions III and IV reduced DC secretion of IL-6, IL-10 and IL-12p40 and expression of CD83, CD86, CCR7 and DC-SIGN compared with control DCs. Proliferation of allogeneic CD4(+) T cells co-cultured with DCs matured with fraction IV, as measured by (3)H-thymidine incorporation, was similar to proliferation of allogeneic CD4(+) T cells co-cultured with control DCs. However, IFN-γ secretion was reduced and IL-10 and IL-17 secretion was increased, a cytokine profile consistent with a Th17 regulatory phenotype. These results indicated that bark from *Betula pubescens* contained compound(s) that could modulate DCs so that their interaction with T cells leads to an immunoregulatory response.

*Betula pubescens* (syn *Betula alba*) aqueous pollen extracts (Bet-APEs) and pollen-associated phytoprostanes were also analyzed for their immunomodulatory capacities in the murine system, both, *in vitro* and *in vivo* ([@bib53]). It has been demonstrated that the pollens modulate human dendritic cell (DC) function in a way that results in an enhanced T(H)2 polarization *in vitro*. DC function was analyzed *in vitro* by using BALB/c bone marrow-derived DCs. T-cell responses were analyzed with DO11.10 peptide 323-339 from chicken ovalbumin (OVA)-specific CD4 T cells as responder cells. For *in vivo* studies, OVA-specific CD4 T cells were adoptively transferred into BALB/c mice. 24 h later, mice were challenged by means of intranasal application of OVA in the absence or presence of Bet-APEs or phytoprostanes. Polarization of T-cell responses *in vivo* was analyzed in draining lymph node cells. *In vitro* Bet-APEs and E(1)-phytoprostanes dose-dependently inhibited LPS-induced IL-12p70 of DCs. In addition, Bet-APEs induced a T(H)2 polarization *in vitro*. Similarly, intranasal instillation of Bet-APEs *in vivo*, together with the antigen, leads to increased IL-4, IL-5, and IL-13 secretion and decreased IFN-gamma secretion from antigen-specific T cells in the draining lymph nodes. In contrast, intranasal E1- and F1-phytoprostanes downregulated both T(H)1 and T(H)2 cytokine production *in vivo*. Thus, *Betula alba* pollen releases water-soluble factors that display T(H)2-polarizing capacities *in vivo* independently of E(1)- and F(1)-phytoprostanes.

5.8. Hepatoprotective {#s0065}
---------------------

[@bib105] showed the 50% aqueous methanolic extract from the bark of *Betula platyphylla* Sukat. var. *japonica* (MIQ). Hara possessed potent inhibitory activity on the liver-injury induced by CCl~4~ or [d]{.smallcaps}-galactosamine ([d]{.smallcaps}-GalN)/lipopolysaccharide as well as O~2~-scavenging and antioxidative activities. From the 50% aqueous methanolic extract, 20 compounds were isolated. Four of these compounds showed protective activity against [d]{.smallcaps}-GalN-induced cytotoxicity in primary cultured rat hepatocytes. Furthermore, several aromatic constituents exhibited potent O~2~-scavenging and antioxidative activities.

In another study, the antifibrotic effects of seven diarylhepanoids, isolated from the n-butanol fraction of the inner bark of *Betula platyphylla*, were evaluated with HSC-T6 cells by assessing cell proliferation ([@bib89]). Among them, four compounds significantly inhibited the proliferation of HSCs in a dose-dependent manner at concentrations from 10 µM to 100 µM. One compound in particular dramatically decreased the collagen content and increased the Caspase-3/7 activity. The results suggested that the antifibrotic activity of *Betula platyphylla* and its constituents might possess therapeutic potential against liver fibrosis.

The ethanolic and aqueous extracts of *Betula utilis* bark were also subjected to *in vitro* and *in vivo* hepatoprotective activity against [d]{.smallcaps}-GalN induced hepatic damage. Since all the biochemical parameters were restored to normal significantly, the findings suggested that *Betula utilis* extracts protect the liver from severe damage caused by [d]{.smallcaps}-galN ([@bib26]).

[@bib148] carried out *in vivo* studies on the hepatoprotective effect of birch (*Betula pubescens* syn. *Betula alba*) bark extract (BBE) in patients with chronic hepatitis C (CHC). After treatment for 12 weeks with 160 mg standardized BBE per day, outcome parameters like alanine aminotransferase (ALT), aspartate aminotransferase (AST) levels, quantitative HCV RNA levels, subjective symptoms associated with CHC (fatigue, abdominal discomfort, depression, and dyspepsia), safety and compliance were monitored and promising results were observed.

5.9. Gastroprotective {#s0070}
---------------------

Methanolic extract of *Betula pendula* leaves (BLE) was evaluated for its gastroprotective effects *in vivo* and the inhibitory activity on lipid peroxidation *in vitro* ([@bib45]). Its gastroprotective effects were studied against 90% ethanol-induced ulcer in rats. Oral pretreatment of rats with BLE (100, 200 and 400 mg kg^−1^) significantly reduced the incidence of gastric lesions induced by ethanol administration as compared with misoprostol (0.50 mg kg^−1^). Furthermore, BLE inhibited the increase in malondialdehyde (MDA) and prevented depletion of total sulhydryl and non-protein sulhydryl groups in rat stomach homogenate when compared with ethanol group. With regard to the effect of lipid peroxidation *in vitro*, BLE showed the ability to reduce methyl linoleate autoxidation. Chemical characterization showed the presence of myricetin-3-O-galactoside, quercetin glycosides, and kaempferol glycosides.

5.10. Miscellaneous {#s0075}
-------------------

*Antidiabetic*: [@bib49] studied the α-glucosidase inhibitory activity of 80% methanolic extract of *Betula alnoides* and its sub-fractions. The 80% methanolic extract had the most powerful α-glucosidase inhibitory effect (98.46%) at a concentration of 40 µg/mL.

[@bib2] reported that the ethanolic extract of the stem wood of *Betula utilis* mildly helped in the decline of bloodglucose of streptozotocin-induced diabetic rats and possessed antihyperglycaemic potential, although it was found to cause respiratory allergy.

*Thromboplastic*: It was determined that the thromboplastic agents from the inflorescence of the *Betula pendula* provoke protective reaction of the animal׳s anticoagulation system, though weaker expressed than the reaction of thromboplastin from brain. The mechanisms of action of thromboplastic agents of plant origin are similar to the mechanism of action of tissue thromboplastin ([@bib86]).

*Phosphodiesterase inhibitory activity*: PDE inhibitors have been used for treatment of many indications such as cardiovascular diseases, chronic obstructive pulmonary diseases, erectile dysfunction and pulmonary hypertension. Some Thai medicinal plants used as aphrodisiac and neurotonic agents were screened for PDE inhibitory activity using a radioassay. 3-isobutyl-1-methylxanthine (IBMX) was used as the standard inhibitor ([@bib158]). IC~50~ values of ethanolic extract of *Betula alnoides* stem bark against PDEs using the SPA radioassay were 3.79±0.98 µg/mL while IBMX standard showed an IC~50~ value of 0.68±0.13 µg/mL. At 0.1 mg/mL, *Betula alnoides* showed complete inhibitory effect against PDEs.

*Aflatoxin production inhibitor*: The essential oil of *Betula pubescens* syn. *Betula alba* yielded methyl syringate which was found to be an inhibitor of aflatoxin production. It inhibited aflatoxin production of *Aspergillus parasiticus* and *Aspergillus flavus* with IC~50~ values of 0.9 and 0.8 mM, respectively, without significantly inhibiting fungal growth. It reduced mRNA levels of genes (aflR, pksA, and omtA) encoding proteins required for aflatoxin biosynthesis. Aflatoxin production inhibitory activities of some related compounds were also studied. However it was found that methyl gallate, methyl 3,4,5-trimethoxybenzoate, and methyl 3-O-methylgallate inhibited both aflatoxin production as well as fungal growth of *Aspergillus parasiticus* and *Aspergillus flavus* ([@bib73]).

Other studies suggest that extracts from *Betula pendula* exhibit mild diuretic activity ([@bib142], [@bib97]) and anti-inflammatory capacity ([@bib162], [@bib160]). They were also used for the supportive treatment of rheumatic diseases in anthroposophic medicine ([@bib124], [@bib50]).

6. Some biologically active triterpenoids from *Betula* species {#s0080}
===============================================================

6.1. Betulin and betulinic acid {#s0085}
-------------------------------

Betulin (lup-20(29)-ene-3β,28-diol) also known as betulinol, betuline and betulinic alcohol, and betulinic acid (3β-hydroxy-lup-20(29)-en-28-oic acid) are two pentacyclic lupane-type triterpenoids that are widely distributed throughout the plant kingdom. Although betulin can also be isolated from other sources in small amounts, the birch bark could be a large and feasible source of raw material for its isolation on an industrial scale. It can be isolated up to 30% dry weight from the birch bark. The birch tree (*Betula* spp.) is one of the most widely reported sources of betulinic acid and betulin which can be obtained in considerable quantities. In recent years, anti-cancer, anti-microbial, anti-inflammatory, differentiation-promoting effects and wound-healing properties of betulin have been described. Betulin can be used as such or after chemical modification as a starting compound for other useful materials and compounds, which possess various interesting pharmacological properties. Betulinic acid has been reported to display a wide range of biological and medicinal properties such as inhibition of human immunodeficiency virus (HIV), anti-bacterial, anti-malarial, anti-inflammatory, anthelmintic, antinociceptive, anti-HSV-1, and anti-cancer activities. Because of its selective cytotoxicity against tumor cells and favorable therapeutic index, even at doses up to 500 mg/kg body weight, betulinic acid is a very promising new chemotherapeutic agent for the treatment of HIV infection and cancer. In a major step toward realizing clinical chemotherapeutic applications for this class of compounds, the University of Illinois at Chicago had licensed the worldwide rights to develop betulinic acid to Advanced Life Sciences, a company specializing in the development of potential new drug candidates in disease categories including viral infections, cancer, and inflammation.

In light of the tremendous interest generated with respect to the chemistry and pharmacological properties of betulinic acid and its analogs, several reviews concerning betulin and particularly its biologically more active derivatives, such as betulinic acid have been published ([@bib8], [@bib20], [@bib29], [@bib3]) in an effort to summarize the available literature about these promising bioactive natural products and identify areas for further research. ([@bib138], [@bib112]).

6.2. Papyriferic acid {#s0090}
---------------------

Another biologically active triterpene isolated from birch trees is Papyriferic acid that is secreted by glands on twigs of the juvenile ontogenetic phase of resin producing tree birches. It deters the browsing by mammals such as the snowshoe hare (*Lepus americanus*) on the juvenile developmental stage of the birch tree ([@bib107], [@bib33]). Since methyl papyriferate was found to exhibit potent reversing effect on cytotoxicity of colchicine against multidrug resistance (MDR) human cancer cells (KB-C2), several papyriferic acid derivatives were prepared and evaluated for their cytotoxicity and effect on reversing P-gp-mediated MDR against KB-C2 cells. It was observed that 3-O-(Morpholino-β-oxopropanoyl)-12β-acetoxy-3α,25-dihydroxy-(20S,24R)-epoxydammarane significantly increased the sensitivity of colchicine against KB-C2 cells by 185-fold at 5 µ/mL (7.4 µM), and the cytotoxicity of colchicine was recovered to nearly that of sensitive (KB) cells. The other several new amide derivatives also exhibited potent reversal activity comparable to or more potent than methyl papyriferate and verapamil ([@bib171]).

7. Toxicity studies {#s0095}
===================

[@bib67], [@bib68] carried out experiments to evaluate the acute oral toxicity of the 50% hydroalchoholic extract as well as its n-butanol fraction (BFBP) obtained from the bark of *Betula platyphylla*. Their single dose toxicities were determined in both sexes of rats at dose of 5.0 g/kg of body weight. After a single oral dose, rats were assigned randomly to two experimental groups, the vehicle (distilled water) group and the treated (5 g/kg) group and monitored during the 14 days after treatment. At this dose the 50% hydroalchoholic extract as well as its BFBP had no effect on mortality, body weight changes, gross findings and clinical signs by biochemical analysis in either sex. Also, *Betula platyphylla* did not cause gastric irritation, erosion, or ulceration up to the orally administered dose of 5 g/kg, thus confirming them to be nontoxic at this dose.

A triterpene rich dry extract extracted from the outer bark of *Betula pubescens* syn. *Betula alba* containing pentacyclic triterpenes, mainly betulin, but also betulinic acid, oleanolic acid, lupeol and erythrodiol was subjected to subchronic toxicity studies. With rats, daily *i.p.* doses of triterpene rich dry extract up to 540 mg/kg for 28 days produced no toxic symptoms or mortality and no histopathological changes were seen ([@bib72]).

Studies have also shown betulin, like other pentacyclic triterpenes, to be non-toxic ([@bib72]). Betulinic acid was also found to be non-toxic at doses up to 500 mg/kg body weight in mice ([@bib126]).

8. Conclusion {#s0100}
=============

The healing properties of birch bark and birch bark extracts have been known for a long time in traditional medicine. Recent studies have shown it to display different biological activities some of which justify their ethnopharmacological uses. Several species of *Betula* have extensively been used for the treatment of osteoarthritis, rheumatism and other bone related problems in different parts of the world, traditionally. Pharmacological studies carried out have supported their traditional use in bone related problems. Studies have shown *Betula platyphylla* and *Betula pendula* to be potentially useful in the treatment of degenerative joint disease ([@bib18], [@bib52], [@bib68]). Experiments have shown that *Betula* species also exhibit anti-inflammatory, immunomodulatory as well as antioxidant activities, all of which contribute towards the protection of joints. Traditional use in bile disorders has also been documented. These find support from the different pharmacological experiments carried out to determine the effect on liver and hepatoprotective action.

Cancer, after cardiovascular disease, is the second leading cause of death. There is a growing importance of triterpenoids as a source of medication for various chronic diseases and several evidences suggest that both natural as well as synthetic triterpenoids have potential anti-cancer activities ([@bib122]). Although *Betula* species are currently at the focus of a variety of projects on novel anticancer agents, no direct ethnobotanical link seems to exist between the traditional uses (*i.e.*, as an anticancer agent) and modern biomedical research. This is not surprising, because only few species have recorded uses as anticancer agents. However, many of these uses imply that the extract will modulate the cell cycle, a property that is explored in the development of novel anticancer agents ([@bib58]). There is convincing evidence in experimental animal models in support of anti-carcinogenic effects of *Betula* bark, betulin as well as betulinic acid. This is in synchronization with the fact that *Betula* is a rich source of triterpenoids especially betulin.

A number of studies have also proven the other biological properties of betulin and betulinic acid: antiviral (antiflu, anti-HIV), anti-inflammatory, antiallergenic, antihypoxic, liver protectant, hypolipemic and antituberculosis. Derivatives of betulinic acid have showed cytotoxicity and anti-HIV activity at micromolar or even at nanomolar concentrations, which are comparable to some clinically used drugs ([@bib138], [@bib153]).

Thus, although the present situation on *Betula* offers a lot of promising prospects, one should also be aware of the shortcomings, possible drawbacks and pitfalls. a) Although betulin and betulinic acid have been the subject of extensive research related to anticancer activity, the other less explored biological activities of *Betula* species, especially their usefulness in the treatment of osteoarthritis, need to be studied in much more detail. b) There is need to study biochemical and physiological mechanisms as well as detailed preclinical toxicity, bioavailability, pharmacokinetics and pharmacodynamics in sufficient detail. c) Controlled clinical trials in the treatment of different conditions would offer fundamental basis for the claims made on them. d) Given the morphological similarities between some species, it is highly likely that species are often substituted with each other for different medicinal uses. Thus, proper quality control protocols, lack of which could lead to misidentification and possible adulteration of the required species, are necessary. e) Finally, an integrated and holistic approach is required for tapping the full potentials of *Betula* species.
